If you or someone you’re caring for takes a generic blood pressure pill every morning without a second thought, this is the kind of recall that’s easy to scroll past — until you realize “generic” doesn’t mean “interchangeable with no differences that matter.” One specific batch of ramipril capsules just failed a quality test it was supposed to pass, and the fix starts with checking a number on your own bottle.
What actually failed, and what it means
The recalled product is 10-milligram ramipril capsules — the generic version of the blood pressure drug Altace — manufactured by Hikma Pharmaceuticals for Exelan Pharmaceuticals. Testing turned up an out-of-specification result tied to a manufacturing impurity called dicyclohexylurea, or DCU — a byproduct that isn’t supposed to be present above a certain level in the finished capsule. The FDA classified this a Class II recall, meaning exposure could cause temporary or reversible health effects, with a serious outcome considered unlikely.
That’s a meaningfully different category than a recall over the drug not working at all. This is a purity issue in how the capsule was made, not a question about whether ramipril itself is safe or effective when it’s made correctly.
How many bottles, and how to tell if yours is one
The recall covers 28,354 bottles total — 25,970 in the 100-count size and 2,384 in the 500-count size. The affected lots are AC5470A (100-count, NDC 76282-673-01) and AC5470B (500-count, NDC 76282-673-05), both expiring July 2027. Hikma initiated the recall August 24, and the FDA finalized the Class II designation September 3.
Check the label on your own bottle for the NDC number and lot code — both are printed on the side, usually in smaller type than the drug name itself. If either number matches, don’t just toss the pills and hope for the best; that’s a conversation for your pharmacist, not a decision to make alone.
Why this isn’t a one-off in this drug class
This recall lands alongside a real pattern worth knowing about: cardiovascular medications have seen several separate quality recalls already in 2026, including valsartan, dabigatran and other heart and blood-pressure drugs pulled over their own manufacturing or impurity issues. That doesn’t mean your specific medication is at elevated risk right now — most batches of most generics are made correctly, every day, without incident. It does mean this particular drug class has had enough of these events this year that checking a lot number when a recall crosses your feed is worth thirty seconds of your time rather than an eye-roll.
What to actually do if you take ramipril
Do not stop taking a blood pressure medication on your own because of a recall headline — stopping abruptly carries its own real risk. The right first step is checking whether your specific bottle matches the recalled lot numbers, and if it does, calling your pharmacist to sort out a replacement before your next dose is due. If you’re not sure which manufacturer made your specific fill, your pharmacy’s records will show it faster than trying to remember from the bottle alone.
A recall on a pill you take every single day can feel more alarming than one on a product you’d only use occasionally — which is exactly why it’s worth handling calmly rather than urgently. Check the lot number, call the pharmacist if it matches, and let the professional whose job this actually is tell you what happens next.
This article was produced with the assistance of AI and reviewed by Womens Overview editors prior to publication.